Related Experiment Videos
Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation
J P Halcox1, S Narayanan, L Cramer-Joyce
1Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Summary
Endothelium-dependent hyperpolarizing factor (EDHF) contributes to human forearm vasodilation. High potassium levels and miconazole inhibited bradykinin responses, suggesting EDHF is a cytochrome P-450 derivative.
Area of Science:
- Cardiovascular Physiology
- Human Microcirculation Research
- Vascular Endothelium Function
Background:
- The precise identity of endothelium-dependent hyperpolarizing factor (EDHF) in human circulation remains a subject of debate.
- Understanding EDHF's role is crucial for comprehending endothelium-dependent vasomotion and potential therapeutic targets.
Purpose of the Study:
- To investigate the contribution of EDHF to endothelium-dependent vasomotion in the human forearm microvasculature.
- To explore the effects of potassium (K+) and miconazole, a cytochrome P-450 inhibitor, on bradykinin-induced vasodilation.
Main Methods:
- Healthy human subjects received intra-arterial infusions of study drugs.
- Forearm blood flow was measured using strain-gauge plethysmography.
- Responses to bradykinin and sodium nitroprusside were assessed under various conditions, including high K+ and after inhibition of nitric oxide and prostaglandin pathways.
Main Results:
- High K+ concentrations significantly inhibited the vasodilator response to bradykinin but not to sodium nitroprusside.
- Miconazole suppressed bradykinin-mediated vasodilation only after nitric oxide synthase and cyclooxygenase inhibition.
- These findings indicate a role for EDHF in nitric oxide- and prostaglandin-independent vasodilation.
Conclusions:
- EDHF contributes to endothelium-dependent vasomotion in the human forearm microvasculature.
- The results suggest that EDHF is likely a cytochrome P-450 derivative, potentially an epoxyeicosatrienoic acid.